Gen-Probe's Prodesse ProFast+ flu assay; Diatherix's STD and herpes diagnostic panels; Mira Dx's PreOvar test for ovarian cancer risk; Seegene's MagicPlex Sepsis and Anyplex MDR-TB assays.
The firm said that its test is the first cleared by FDA for molecular detection of HSV.
EraGen Biosciences gets 510(k) clearance for PCR-based HSV IVD; Molecular Detection and Launch Diagnostics launch Detect-Ready MRSA assay.
Quidel said that Diagnostic Hybrids' fluorescent in vitro diagnostic assays would complement Quidel's point-of-care diagnostics for infectious disease and reproductive health.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.